PG Procter & Gamble

Q4 2025 10-Q

Filed: Jan 23, 2026Period ending Dec 31, 2025

Health Care

Soap, Detergents, Cleang Preparations, Perfumes, CosmeticsSEC EDGAR

Procter & Gamble (PG) 10-Q quarterly report for Q4 2025, filed with SEC EDGAR on Jan 23, 2026 for the fiscal period ending Dec 31, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q4 2025 10-Q

Management Discussion & Analysis

• Quarterly revenue $22.2B, up 1% YoY from $21.9B; organic sales flat excluding acquisitions/divestitures and FX
• Operating margin 24.2% vs 26.2% YoY; net earnings margin 19.4% vs 21.2%; net earnings down 7% to $4.3B; diluted EPS $1.78 vs $1.88 (-5%)

+3 more insights

Risk Factors

• No new or changed risk factors reported this quarter versus the fiscal 2025 10-K
• Continuing supply chain disruptions risk impacting raw material availability and production costs

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$22.2B

▲ +1.5% YoY▼ -0.8% QoQ

Net Income

$4.3B

▼ -6.7% YoY▼ -9.1% QoQ

Net Margin

19.5%

▼ -171bp YoY▼ -177bp QoQ

Source: XBRL data from Procter & Gamble Q4 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on Procter & Gamble

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.